Study of an experimental drug for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called XNW29016 for people with advanced cancer that has stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have advanced solid tumor cancer that has not responded to standard therapy.
- You are willing to provide a tumor tissue sample for testing.
- You are able to perform daily activities with minimal help (ECOG score 0 or 1).
- Your major organs (like bone marrow, liver, kidneys) are working well enough based on blood tests.
- You have not had a PARG inhibitor drug before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral drug called SIGX1094R for people with advanced solid tumors that have not responded to other treatments. The study will check if the drug is safe and how well it works, and it requires a tumor tissue sample to look for a specific marker.
This trial tests a new drug called XNW28012 for people with advanced solid tumors that have not responded to or caused side effects from standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
This study tests an experimental drug called XNW34017 in people with advanced or metastatic solid tumors, especially small cell lung cancer and prostate cancer that have progressed despite prior treatments. The goal is to see if the drug is safe and effective for these cancers.
This study tests a new experimental drug (NWY001) for people with advanced solid tumors that have stopped responding to standard treatments. It is a phase 1 trial, meaning it is early research to find the right dose and check for side effects.
This study tests a new drug, 9MW2821, either alone or with other cancer treatments, for people with advanced solid tumors. The goal is to see if it can shrink or control the cancer and to check its safety.
This trial studies a new drug called HW071021 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can help shrink or control the cancer.
Hear when a new Tumor, Solid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.